Abstract
The confluence of a high burden of infections, overcrowded conditions, poor hygiene, and lack of access to newer antibiotics in large, urban, public hospitals in poor countries is leading to higher reported levels of antibiotic resistance. Most resistance data come from the sickest patients and those who do not respond to any antibiotics; therefore, reported rates may overstate the problem. Nevertheless, it is evident that lack of diagnostic and other microbiologic resources encourage overtreatment and contribute to mistreatment in hospitals. High national death rates from childhood pneumonia in the community indicate a lack of access and underuse. Hospital-acquired infections (HAIs) impose significant health costs in poor countries where people pay for health care out of pocket. Patients, especially neonates, are more likely to die for lack of effective treatment and are likely to be ill and infectious for longer, hence more likely to spread resistant organisms. Underused but highly cost-effective interventions include vaccination to reduce disease burden (benefiting the entire population, not just hospitals), improved hospital infection control (which can be relatively inexpensive), and changing incentives toward more appropriate antibiotic use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbett SK, Yokoe DS, Lipsitz SR, Bader AM, Berry WR, Tamplin EM, Gawande AA (2009) Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 30: 1062–1069
Amábile-Cuevas CF (2010) Global Perspectives of Antibiotic Resistance. Pages 3–13 in Sosa AdJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, Foster SD, eds. Antimicrobial Resistance in Developing Countries, Springer, New York
Aswapokee N, Vaithayapichet S, Heller R (1990) Pattern of antibiotic use in medical wards of a university hospital, Bangkok, Thailand. Rev Infect Dis 12: 136–141
Bartoloni A, Gotuzzo E (2010) Bacterial-Resistant Infections in Resource-Limited Countries. Pages 199–232 in Sosa A, Byarugaba D, Amabile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, eds. Antimicrobial Resistance in Developing Countries, Springer, New York
Bejon P, Mwangi I, Ngetsa C, Mwarumba S, Berkley JA, Lowe BS, Maitland K, Marsh K, English M, Scott JAG (2005) Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya. Journal of Antimicrobial Chemotherapy 56: 232–235
Berkley JA, Maitland K, Mwangi I, Ngetsa C, Mwarumba S, Lowe BS, Newton CR, Marsh K, Scott JA, English M (2005) Use of clinical syndromes to target antibiotic prescribing in seriously ill children in malaria endemic area: observational study. Br. Med. J. 330
Blomberg B et al. (2005) High rate of fatal cases of pediatric septicemia caused by Gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 43: 745–749
(2007) Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study. BMC Infect Dis 7
Chowdhury A, Khan O, Matin M, Begum K, Galib M (2007) Effect of standard treatment guidelines with or without prescription audit on prescribing for acute respiratory tract infection (ARI) and diarrhoea in some thana health complexes (THCs) of Bangladesh. Bangladesh Med Res Counc Bull 33: 21–30
Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth GJ, Lai R, Ebrahim S (2005) Systematic review of isolation policies in the hospital management of methicillinresistant Staphylococcus aureus: a review of the literature with epidemiological and economic modeling. International Journal of Technology Assessment in Health Care 21: 146–146
Cosgrove S, Qi Y, Kaye K, Harbarth S, Karchmer A, Carmeli Y (2005) The impact of methicillin resistance in staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26: 166–174
Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 36: 1433–1437
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality related to methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a metaanalysis. Clin Infect Dis 36: 53–59
Einarsson S, Kristjansson M, Kristinsson KG, Gudbrandur K, Steinn J (1998) Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study. Scandinavian Journal of Infectious Diseases 30: 253–256
El-Astal Z (2004) Bacterial pathogens and their antimicrobial susceptibility in Gaza Strip, Palestine. Pak J Med Sci 20: 365–370
English M, Esamai F, Wasunna A, Were F, Ogutu B, Wamae A, Snow RW, Peshu N (2004) Assessment of inpatient pediatric care in first referral level hospitals in 13 districts in Kenya. Lancet 363: 1948–1953
EPN (2010) An exploratory pilot study on knowledge, attitudes and perceptions on antimicrobial resistance and antibiotic use practices among hospital staff in Kenya. Unpublished, ecumenical pharmaceutical network, Nairobi, Kenya
Farr BM (2000) Reasons for non-compliance with infection control guidelines. Infect Control Hosp Epidemiol 21: 411–416
Forster SD (2010) The economic burden of antimicrobial resistance in the developing world. Pages 365–384 in Sosa AdJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, Foster SD, eds. Antimicrobial resistance in developing countries, Springer, New York
Franco-Paredes C, Santos-Preciado J (2010) The introduction of antimicrobial agents in resource-constrained countries: Impact on the emergence of resistance. Pages 59–69 in Sosa A, Byarugaba D, Amabile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, eds. Antimicrobial resistance in developing countries, Springer, New York
Frist B, Sezibera R (2009) Time for renewed global action against childhood pneumonia. Lancet 374
Goodman C et al. (2001) Changing the first line drug for malaria treatment and cost-effectiveness analysis with highly uncertain inter-temporal trade-off. Health Economics 10: 731–749
Group MN (2008) Antibiotic overuse: the influence of social norms. Journal of the American College of Surgeons 207: 265–275
Guyon A, Barman A, Ahmed J, Ahmed A, Alam M (1994) A baseline survey on use of drugs at the primary health care level in Bangladesh. Bull World Health Organ 72: 265–271
Haak H, Radyowijati A (2010) Determinants of antimicrobial use: Poorly understood--poorly researched. Pages 283–300 in Sosa AdJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, eds. Antimicrobial resistance in developing countries, Springer, New York
HaRP (2009) Challenges for global health; focus area: diarrheal diseases. USAID http://www.harpnet.org/about/index.html Accessed 23 September 2010
Hart CA, Kariuki S (1998) Antimicrobial resistance in developing countries. BMJ 317
Haynes AB et al. (2009) A surgical safety checklist to reduce morbidity and mortality in a global population. New England Journal of Medicine 360: 491–499
Howard D (2004) Resistance-induced antibiotic substitution. Health Econ 13: 585–595
Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK (2003) Prevalence of extended-spectrum beta-lactamaseproducing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. Journal of Medical Microbiology 52: 421–425
Kakai R, Wamola I (2002) Minimizing antibiotic resistance to Staphylococcus aureus in developing countries. East African Medical Journal 79: 574–580
Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Hart CA (2006) Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrheal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiology 6
Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE (2010) Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza- Tanzania. BMC Pediatrics 10
Larson EL, Quiros D, Lin SX (2007) Dissemination of the CDC’s Hand Hygiene Guideline and impact on infection rates. American Journal of Infection Control 35: 666–675
Lautenbach E, Patel J, Bilker W, Edelstein P, Fishman N (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32: 1162–1171
Laxminarayan R (2001) Fighting antibiotic resistance: can economic incentives play a role? Resources 143: 9–12
(2002) Antibiotic resistance: an emerging environmental health threat. Issue Brief 02–19, Resources for the Future, Washington DC
(2003a) Economic responses to the problem of drug resistance. Pages 121–127 in Knobler SL, Lemon SM, Najafi M, Burroughs T, eds. The resistance phenomenon in microbes and infectious disease vectors: Implications for human health and strategies for containment. National Academies Press, Washington, DC
(2003b) Battling resistance to antibiotics and pesticides: An economic approach. RFF Press, Washington, DC
Laxminarayan R, Smith DL, Real LA, Levin SA (2005) On the importance of incentives in hospital infection control spending. Discovery Medicine 5(27): 303–308
Laxminarayan R, Malani A (2007) Extending the cure: Policy responses to the growing threat of antibiotic resistance. Resources for the future, Washington, DC
Le Grand A, Hogerzeil H, Haaijer-Ruskamp F (1999) Intervention research in rational use of drugs: a review. Health Policy and Planning 14: 89–102
Lennell A, Kuhlmann-Berenzon S, Geli P, Hedin K, Petersson C, Cars O, Mannerquist K, Burman LG, Fredlund H (2008) Alcohol-based hand-disinfection reduced children’s absence from Swedish day care centers. Acta Paediatr 97: 1672–1680
Madhi SA et al. (2000) Impact of human immuno-deficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. J Pediatric Infect Dis 19(12): 1141–1147
Mauldin P, Salgado C, Hansen I, Durup D, Bosso J (2010) Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant Gram-negative bacteria. Antimicrob Agents Chemother 54: 109–115
Mir F, Zaidi AKM (2010) Hospital infections by antimicrobial-resistant organisms in developing countries. Pages 347–362 in Sosa AdJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, eds. Antimicrobial resistance in developing countries, Springer, New York
Mitema E, Kikuvi G (2004) Surveillance of the overall use of antimicrobial drugs in humans over a 5 year period (1997–2001) in Kenya. Journal of Antimicrobial Chemotherapy 54: 966–967
Musoke R, Revathi G (2000) Emergence of multidrug-resistant Gram-negative organisms in a neonatal unit and the therapeutic implications. Journal of Tropical Pediatrics 46: 86–91
Naivalulevu L (1990) Training for rational drug use. ARI News 18
Newton O, English M (2007) Young infant sepsis: aetiology, antibiotic susceptibility and clinical signs. Trans R Soc Trop Med Hyg 101: 959–966
Okeke IN, Aboderin OA, Byarugaba D, Ojo KK, Opintan JA (2007) Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis 13: 1640–1647
Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, Pablos-Mendez A, Klugman KP (2005a) Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 5: 481–493
Okeke IN, Klugman K, Bhutta ZA, Duse A, Jenkins P, O’Brien TF, Pablos-Mendez A, Laxminarayan L (2005b) Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis 5: 568–580
Pemba L et al. (2008) Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. J Infect 56:171–178
Phillips-Howard PA et al. (2003) Efficacy of permethrin-treated bed nets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya. Am J Trop Med Hyg 68: 23–29
Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV (2000) Effectiveness of a hospital-wide program to improve compliance with hand hygiene. Lancet 356: 1307–1312
Pittet D, Allegranzi B, Sax H, Dharan S, Pessoa-Silva CL, Donaldson L, Boyce JM (2006) Evidence-based model for hand transmission during patient care and the role of improved practices. LANINF 6: 641–652
Ram PK (2008) Community case management of childhood diarrhoea in Asembo and Kibera, Kenya, 2007. University at Buffalo, Centers for Disease Control and Prevention, the Ministry of Health of the Republic of Kenya, and U.S. Agency for International Development
REACT (2008) Economic Aspects on Antibiotic Resistance. REACT website. http://soapimg.icecube.snowfall.se/strama/BoR%20Economic%20Aspects.pdf Accessed 23 September 2010
Rhinehart E, Goldmann DA, Rourke EJO (1991) Adaptation of the centers for disease control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am J Medicine 91: S213-S220
Rosenthal VD, Guzman S, Safdar N (2005) Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 33: 392–397
Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ (2003) Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 31: 405–409
Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H (2008) Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86: 408–416
Scott JAG et al. (2005) Progressive increase in antimicrobial resistance among invasive isolates of Haemophilus influenzae obtained from children admitted to a hospital in Kilifi, Kenya, from 1994 to 2002. Antimicrob Agents Chemother 49: 3021–3024
Shapiro RL et al. (2001) Antimicrobial-resistant bacterial diarrhea in rural Western Kenya. J Infect Dis 183: 1701–1704
Slama T (2008) Gram-negative antibiotic resistance: there is a price to pay. Crit Care Med 12: S4
Smith RD, Coast J (1998) Controlling antimicrobial resistance: a proposed transferable permit market. Health Policy 43: 219–232
(2002) Antimicrobial resistance: a global response. Bull World Health Organ 80: 126–133
Smith DL, Levin SA, Laxminarayan R (2005) Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A 102: 3153–3158
Thompson RL, Cabezudo I, Wenzel RP (1982) Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 97: 309–317
Uppal R, Sarkar U, Giriyappanavar C, Kacker V (1993) Antimicrobial drug use in primary health care. J Clin Epidemiol 46: 671–673
WHO (2009a) World Health Statistics 2009. Geneva.
(2009b) Acute Respiratory Infections. WHO Initiative for Vaccine Research http://www.who.int/vaccine_research/diseases/ari/en/index.html Accessed 23 September 2010
WHO India (2007) Standard treatment guidelines: Medical management of costing of select conditions. WHO Standard treatment guidelines, India
Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC (2008) Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359: 1555–1564
Zimmerman PA (2007) Help or hindrance? Is current infection control advice applicable in low- and middle-income countries? A review of the literature. Am J Infect Control 35: 494–500
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Winters, C., Gelband, H. (2012). Multidrug-Resistant Infections in Low-Resource Health Care Settings. In: Gould, I., van der Meer, J. (eds) Antibiotic Policies. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1734-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1734-8_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1733-1
Online ISBN: 978-1-4419-1734-8
eBook Packages: MedicineMedicine (R0)